Effects of statins and steroids on coronary artery disease and stroke in patients with interstitial lung disease and pulmonary fibrosis: A general population study
To determine the effects of statins and steroids on the risk of coronary artery disease (CAD) and stroke in patients with interstitial lung disease and pulmonary fibrosis (ILD-PF). We retrospectively enrolled patients with ILD-PF who were using statins (statin cohort, N = 11,567) and not using stati...
Saved in:
Published in | PloS one Vol. 16; no. 10; p. e0259153 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
San Francisco
Public Library of Science
27.10.2021
Public Library of Science (PLoS) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | To determine the effects of statins and steroids on the risk of coronary artery disease (CAD) and stroke in patients with interstitial lung disease and pulmonary fibrosis (ILD-PF). We retrospectively enrolled patients with ILD-PF who were using statins (statin cohort, N = 11,567) and not using statins (nonstatin cohort, N = 26,159). Cox proportional regression was performed to analyze the cumulative incidence of CAD and stroke. Adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs) of CAD and stroke were determined after sex, age, and comorbidities, as well as the use of inhaler corticosteroids (ICSs), oral steroids (OSs), and statins, were controlled for. Compared with those of patients without statin use, the aHRs (95% CIs) of patients with statin use for CAD and ischemic stroke were 0.72 (0.65-0.79) and 0.52 (0.38-0.72), respectively. For patients taking single-use statins but not ICSs/OSs, the aHRs (95% CIs) for CAD and ischemic stroke were 0.72 (0.65-0.79)/0.69 (0.61-0.79) and 0.54 (0.39-0.74)/0.50 (0.32-0.79), respectively. For patients using ICSs/OSs, the aHRs (95% CIs) for CAD and ischemic stroke were 0.71 (0.42-1.18)/0.74 (0.64-0.85) and 0.23 (0.03-1.59)/0.54 (0.35-0.85), respectively. The findings demonstrate that statin use, either alone or in combination with OS use, plays an auxiliary role in the management of CAD and ischemic stroke in patients with ILD-PF. |
---|---|
AbstractList | To determine the effects of statins and steroids on the risk of coronary artery disease (CAD) and stroke in patients with interstitial lung disease and pulmonary fibrosis (ILD-PF). We retrospectively enrolled patients with ILD-PF who were using statins (statin cohort, N = 11,567) and not using statins (nonstatin cohort, N = 26,159). Cox proportional regression was performed to analyze the cumulative incidence of CAD and stroke. Adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs) of CAD and stroke were determined after sex, age, and comorbidities, as well as the use of inhaler corticosteroids (ICSs), oral steroids (OSs), and statins, were controlled for. Compared with those of patients without statin use, the aHRs (95% CIs) of patients with statin use for CAD and ischemic stroke were 0.72 (0.65-0.79) and 0.52 (0.38-0.72), respectively. For patients taking single-use statins but not ICSs/OSs, the aHRs (95% CIs) for CAD and ischemic stroke were 0.72 (0.65-0.79)/0.69 (0.61-0.79) and 0.54 (0.39-0.74)/0.50 (0.32-0.79), respectively. For patients using ICSs/OSs, the aHRs (95% CIs) for CAD and ischemic stroke were 0.71 (0.42-1.18)/0.74 (0.64-0.85) and 0.23 (0.03-1.59)/0.54 (0.35-0.85), respectively. The findings demonstrate that statin use, either alone or in combination with OS use, plays an auxiliary role in the management of CAD and ischemic stroke in patients with ILD-PF. Purpose To determine the effects of statins and steroids on the risk of coronary artery disease (CAD) and stroke in patients with interstitial lung disease and pulmonary fibrosis (ILD-PF). Methods We retrospectively enrolled patients with ILD-PF who were using statins (statin cohort, N = 11,567) and not using statins (nonstatin cohort, N = 26,159). Cox proportional regression was performed to analyze the cumulative incidence of CAD and stroke. Adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs) of CAD and stroke were determined after sex, age, and comorbidities, as well as the use of inhaler corticosteroids (ICSs), oral steroids (OSs), and statins, were controlled for. Results Compared with those of patients without statin use, the aHRs (95% CIs) of patients with statin use for CAD and ischemic stroke were 0.72 (0.65-0.79) and 0.52 (0.38-0.72), respectively. For patients taking single-use statins but not ICSs/OSs, the aHRs (95% CIs) for CAD and ischemic stroke were 0.72 (0.65-0.79)/0.69 (0.61-0.79) and 0.54 (0.39-0.74)/0.50 (0.32-0.79), respectively. For patients using ICSs/OSs, the aHRs (95% CIs) for CAD and ischemic stroke were 0.71 (0.42-1.18)/0.74 (0.64-0.85) and 0.23 (0.03-1.59)/0.54 (0.35-0.85), respectively. Conclusions The findings demonstrate that statin use, either alone or in combination with OS use, plays an auxiliary role in the management of CAD and ischemic stroke in patients with ILD-PF. Purpose To determine the effects of statins and steroids on the risk of coronary artery disease (CAD) and stroke in patients with interstitial lung disease and pulmonary fibrosis (ILD-PF). Methods We retrospectively enrolled patients with ILD-PF who were using statins (statin cohort, N = 11,567) and not using statins (nonstatin cohort, N = 26,159). Cox proportional regression was performed to analyze the cumulative incidence of CAD and stroke. Adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs) of CAD and stroke were determined after sex, age, and comorbidities, as well as the use of inhaler corticosteroids (ICSs), oral steroids (OSs), and statins, were controlled for. Results Compared with those of patients without statin use, the aHRs (95% CIs) of patients with statin use for CAD and ischemic stroke were 0.72 (0.65–0.79) and 0.52 (0.38–0.72), respectively. For patients taking single-use statins but not ICSs/OSs, the aHRs (95% CIs) for CAD and ischemic stroke were 0.72 (0.65–0.79)/0.69 (0.61–0.79) and 0.54 (0.39–0.74)/0.50 (0.32–0.79), respectively. For patients using ICSs/OSs, the aHRs (95% CIs) for CAD and ischemic stroke were 0.71 (0.42–1.18)/0.74 (0.64–0.85) and 0.23 (0.03–1.59)/0.54 (0.35–0.85), respectively. Conclusions The findings demonstrate that statin use, either alone or in combination with OS use, plays an auxiliary role in the management of CAD and ischemic stroke in patients with ILD-PF. To determine the effects of statins and steroids on the risk of coronary artery disease (CAD) and stroke in patients with interstitial lung disease and pulmonary fibrosis (ILD-PF).PURPOSETo determine the effects of statins and steroids on the risk of coronary artery disease (CAD) and stroke in patients with interstitial lung disease and pulmonary fibrosis (ILD-PF).We retrospectively enrolled patients with ILD-PF who were using statins (statin cohort, N = 11,567) and not using statins (nonstatin cohort, N = 26,159). Cox proportional regression was performed to analyze the cumulative incidence of CAD and stroke. Adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs) of CAD and stroke were determined after sex, age, and comorbidities, as well as the use of inhaler corticosteroids (ICSs), oral steroids (OSs), and statins, were controlled for.METHODSWe retrospectively enrolled patients with ILD-PF who were using statins (statin cohort, N = 11,567) and not using statins (nonstatin cohort, N = 26,159). Cox proportional regression was performed to analyze the cumulative incidence of CAD and stroke. Adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs) of CAD and stroke were determined after sex, age, and comorbidities, as well as the use of inhaler corticosteroids (ICSs), oral steroids (OSs), and statins, were controlled for.Compared with those of patients without statin use, the aHRs (95% CIs) of patients with statin use for CAD and ischemic stroke were 0.72 (0.65-0.79) and 0.52 (0.38-0.72), respectively. For patients taking single-use statins but not ICSs/OSs, the aHRs (95% CIs) for CAD and ischemic stroke were 0.72 (0.65-0.79)/0.69 (0.61-0.79) and 0.54 (0.39-0.74)/0.50 (0.32-0.79), respectively. For patients using ICSs/OSs, the aHRs (95% CIs) for CAD and ischemic stroke were 0.71 (0.42-1.18)/0.74 (0.64-0.85) and 0.23 (0.03-1.59)/0.54 (0.35-0.85), respectively.RESULTSCompared with those of patients without statin use, the aHRs (95% CIs) of patients with statin use for CAD and ischemic stroke were 0.72 (0.65-0.79) and 0.52 (0.38-0.72), respectively. For patients taking single-use statins but not ICSs/OSs, the aHRs (95% CIs) for CAD and ischemic stroke were 0.72 (0.65-0.79)/0.69 (0.61-0.79) and 0.54 (0.39-0.74)/0.50 (0.32-0.79), respectively. For patients using ICSs/OSs, the aHRs (95% CIs) for CAD and ischemic stroke were 0.71 (0.42-1.18)/0.74 (0.64-0.85) and 0.23 (0.03-1.59)/0.54 (0.35-0.85), respectively.The findings demonstrate that statin use, either alone or in combination with OS use, plays an auxiliary role in the management of CAD and ischemic stroke in patients with ILD-PF.CONCLUSIONSThe findings demonstrate that statin use, either alone or in combination with OS use, plays an auxiliary role in the management of CAD and ischemic stroke in patients with ILD-PF. PurposeTo determine the effects of statins and steroids on the risk of coronary artery disease (CAD) and stroke in patients with interstitial lung disease and pulmonary fibrosis (ILD-PF).MethodsWe retrospectively enrolled patients with ILD-PF who were using statins (statin cohort, N = 11,567) and not using statins (nonstatin cohort, N = 26,159). Cox proportional regression was performed to analyze the cumulative incidence of CAD and stroke. Adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs) of CAD and stroke were determined after sex, age, and comorbidities, as well as the use of inhaler corticosteroids (ICSs), oral steroids (OSs), and statins, were controlled for.ResultsCompared with those of patients without statin use, the aHRs (95% CIs) of patients with statin use for CAD and ischemic stroke were 0.72 (0.65-0.79) and 0.52 (0.38-0.72), respectively. For patients taking single-use statins but not ICSs/OSs, the aHRs (95% CIs) for CAD and ischemic stroke were 0.72 (0.65-0.79)/0.69 (0.61-0.79) and 0.54 (0.39-0.74)/0.50 (0.32-0.79), respectively. For patients using ICSs/OSs, the aHRs (95% CIs) for CAD and ischemic stroke were 0.71 (0.42-1.18)/0.74 (0.64-0.85) and 0.23 (0.03-1.59)/0.54 (0.35-0.85), respectively.ConclusionsThe findings demonstrate that statin use, either alone or in combination with OS use, plays an auxiliary role in the management of CAD and ischemic stroke in patients with ILD-PF. |
Audience | Academic |
Author | Yeh, Jun-Jun Hsu, Nai-Hua Lin, Cheng-Li Kao, Chia-Hung |
AuthorAffiliation | 2 China medical university, Taichung, Taiwan Universitaria di Bologna, ITALY 3 Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan 7 Department of Bioinformatics and Medical Engineering, Asia University, Taichung, Taiwan 6 Department of Nuclear Medicine and PET Center, China Medical University Hospital, Taichung, Taiwan 8 Center of Augmented Intelligence in Healthcare, China Medical University Hospital, Taichung, Taiwan 5 Graduate Institute of Biomedical Sciences, College of Medicine, China Medical University, Taichung, Taiwan 1 Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi, Taiwan 4 College of Medicine, China Medical University, Taichung, Taiwan |
AuthorAffiliation_xml | – name: Universitaria di Bologna, ITALY – name: 1 Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi, Taiwan – name: 8 Center of Augmented Intelligence in Healthcare, China Medical University Hospital, Taichung, Taiwan – name: 4 College of Medicine, China Medical University, Taichung, Taiwan – name: 7 Department of Bioinformatics and Medical Engineering, Asia University, Taichung, Taiwan – name: 2 China medical university, Taichung, Taiwan – name: 3 Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan – name: 5 Graduate Institute of Biomedical Sciences, College of Medicine, China Medical University, Taichung, Taiwan – name: 6 Department of Nuclear Medicine and PET Center, China Medical University Hospital, Taichung, Taiwan |
Author_xml | – sequence: 1 givenname: Jun-Jun orcidid: 0000-0002-4368-7880 surname: Yeh fullname: Yeh, Jun-Jun – sequence: 2 givenname: Cheng-Li surname: Lin fullname: Lin, Cheng-Li – sequence: 3 givenname: Nai-Hua surname: Hsu fullname: Hsu, Nai-Hua – sequence: 4 givenname: Chia-Hung orcidid: 0000-0002-6368-3676 surname: Kao fullname: Kao, Chia-Hung |
BookMark | eNqNk2uL1DAUhousuBf9B4IFQfTDjOklabofhGFZdWBhwdvXkObSyZpJapOq83v8o57OdGG7LCL90PLmed_knJ6cJkfOO5UkzzO0zIoqe3vjh95xu-xAXqIc1xkuHiUnWV3kC5Kj4ujO93FyGsINQrighDxJjouyQpji7CT5c6m1EjGkXqch8mhcSLmT8K16byToLhW-9473u5T3oO5SaYLiQU1c77-r1Li0A7NykPTLxA0IgIZoouE2tYNrZ65usNtDpDZN74MJ5-kqbZVTPeCdh3VIg61DHOTuafJYcxvUs-l9lnx9f_nl4uPi6vrD-mJ1tRCE1HFBSEOF1pIShWoqm4biWqIyV2WVlbIWtEAa9AoBl40rNVakqTSRsgGJFmfJi0NuZ31gU38DyzElNUUFGYn1gZCe37CuN1uogXlu2F7wfcugR0ZYxbhCpKQoK3WNykbTWuQ4IzLL80IQTgRkvZt2G5qtkgJ6B8XPQucrzmxY638yijEqCwIBr6eA3v8YVIhsa4JQ1nKn_LA_d1XhvKwrQF_eQx-ubqJaDgUYpz3sK8ZQtiKA0IpgBNTyAQoeqbZGwDBqA_rM8GZmACaq37HlQwhs_fnT_7PX3-bsqzvsRnEbN8HbYRycMAfPD6CAUQu90kyYuJ8vOLmxLENsvFG3PWHjjWLTjQJzec98-4f-afsLZLEpWQ |
CitedBy_id | crossref_primary_10_1186_s40001_024_01836_1 crossref_primary_10_3390_metabo14060292 crossref_primary_10_3390_biomedicines10061290 crossref_primary_10_3389_fcvm_2022_925211 crossref_primary_10_3389_fcvm_2022_797623 |
Cites_doi | 10.1001/jamainternmed.2020.0994 10.1093/eurheartj/ehaa231 10.1186/1472-6963-13-152 10.1016/j.chest.2019.04.015 10.1093/ehjcvp/pvaa042 10.1016/j.chest.2017.03.033 10.1002/pds.2338 10.1136/annrheumdis-2020-217442 10.3906/sag-2004-168 10.1016/S0140-6736(10)62174-5 10.1183/13993003.02419-2016 10.1183/09059180.00000713 10.1002/pds.3864 10.1038/cddis.2017.260 10.1161/JAHA.118.011320 10.1378/chest.14-3138 10.1016/j.rmed.2011.03.020 10.1056/NEJMc2015630 10.2188/jea.JE20140076 10.1038/s41598-020-74492-0 10.1513/AnnalsATS.201610-764OC 10.2147/CLEP.S196293 10.1016/j.chest.2019.10.032 10.1007/s11892-019-1178-6 10.1016/j.jfma.2013.09.009 10.1186/s12906-018-2384-5 10.1128/mBio.00398-20 10.1136/thoraxjnl-2016-208819 10.1016/j.jacc.2018.02.006 10.3389/fmed.2020.00170 10.1152/ajplung.00344.2017 10.1371/journal.pone.0140571 10.1183/16000617.0077-2018 10.1111/ijcp.14066 10.3389/fpsyt.2019.00103 10.1016/j.rmed.2012.07.012 10.1136/thx.2004.030205 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2021 Public Library of Science 2021 Yeh et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2021 Yeh et al 2021 Yeh et al |
Copyright_xml | – notice: COPYRIGHT 2021 Public Library of Science – notice: 2021 Yeh et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2021 Yeh et al 2021 Yeh et al |
DBID | AAYXX CITATION IOV ISR 3V. 7QG 7QL 7QO 7RV 7SN 7SS 7T5 7TG 7TM 7U9 7X2 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU COVID D1I DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M7N M7P M7S NAPCQ P5Z P62 P64 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PTHSS PYCSY RC3 7X8 5PM DOA |
DOI | 10.1371/journal.pone.0259153 |
DatabaseName | CrossRef Gale In Context: Opposing Viewpoints Gale In Context: Science ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts Nursing & Allied Health Database Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Meteorological & Geoastrophysical Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Journals ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Collection ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Coronavirus Research Database ProQuest Materials Science Collection ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Materials Science Database Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection Biological Sciences Agricultural Science Database Health & Medical Collection (Alumni) Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Engineering Database Nursing & Allied Health Premium Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Materials Science Collection ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition Engineering Collection Environmental Science Collection Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef Agricultural Science Database Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection Coronavirus Research Database ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Meteorological & Geoastrophysical Abstracts - Academic ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Materials Science Collection ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Agricultural Science Database |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Sciences (General) |
DocumentTitleAlternate | Effects of statins and steroids on CAD and stroke among patients with ILD-PF |
EISSN | 1932-6203 |
ExternalDocumentID | 2586980368 oai_doaj_org_article_ae0648014f904bf89c2516d1223c6a6c PMC8550436 A680387650 10_1371_journal_pone_0259153 |
GeographicLocations | Taiwan China |
GeographicLocations_xml | – name: Taiwan – name: China |
GrantInformation_xml | – fundername: ; – fundername: ; grantid: MOHW110-TDU-B-212-124004 – fundername: ; grantid: CMU107-ASIA-19, DMR-109-231 – fundername: ; grantid: MOST 108-2321-B-039-003 |
GroupedDBID | --- 123 29O 2WC 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ AAUCC AAWOE AAYXX ABDBF ABIVO ABJCF ABUWG ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAWUL BBNVY BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CITATION CS3 D1I D1J D1K DIK DU5 E3Z EAP EAS EBD EMOBN ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IGS IHR IHW INH INR IOV IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ O5R O5S OK1 OVT P2P P62 PATMY PDBOC PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO PTHSS PV9 PYCSY RNS RPM RZL SV3 TR2 UKHRP WOQ WOW ~02 ~KM BBORY PMFND 3V. 7QG 7QL 7QO 7SN 7SS 7T5 7TG 7TM 7U9 7XB 8FD 8FK AZQEC C1K COVID DWQXO FR3 GNUQQ H94 K9. KL. M7N P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI RC3 7X8 5PM PUEGO - 02 AAPBV ABPTK ADACO BBAFP KM |
ID | FETCH-LOGICAL-c669t-66b8cffd86e098dbb859d042e4714d9c830f98d706b819d0495e6b7f6ddb6b883 |
IEDL.DBID | M48 |
ISSN | 1932-6203 |
IngestDate | Fri Nov 26 17:11:54 EST 2021 Wed Aug 27 01:22:59 EDT 2025 Thu Aug 21 14:20:56 EDT 2025 Fri Jul 11 05:37:52 EDT 2025 Fri Jul 25 11:25:54 EDT 2025 Tue Jun 17 21:36:12 EDT 2025 Tue Jun 10 20:46:01 EDT 2025 Fri Jun 27 05:02:02 EDT 2025 Fri Jun 27 04:17:26 EDT 2025 Thu May 22 21:23:24 EDT 2025 Tue Jul 01 03:58:58 EDT 2025 Thu Apr 24 22:53:20 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Language | English |
License | This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Creative Commons Attribution License |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c669t-66b8cffd86e098dbb859d042e4714d9c830f98d706b819d0495e6b7f6ddb6b883 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Competing Interests: The authors have declared that no competing interests exist. |
ORCID | 0000-0002-4368-7880 0000-0002-6368-3676 |
OpenAccessLink | https://doaj.org/article/ae0648014f904bf89c2516d1223c6a6c |
PMID | 34705851 |
PQID | 2586980368 |
PQPubID | 1436336 |
PageCount | e0259153 |
ParticipantIDs | plos_journals_2586980368 doaj_primary_oai_doaj_org_article_ae0648014f904bf89c2516d1223c6a6c pubmedcentral_primary_oai_pubmedcentral_nih_gov_8550436 proquest_miscellaneous_2587752497 proquest_journals_2586980368 gale_infotracmisc_A680387650 gale_infotracacademiconefile_A680387650 gale_incontextgauss_ISR_A680387650 gale_incontextgauss_IOV_A680387650 gale_healthsolutions_A680387650 crossref_citationtrail_10_1371_journal_pone_0259153 crossref_primary_10_1371_journal_pone_0259153 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-10-27 |
PublicationDateYYYYMMDD | 2021-10-27 |
PublicationDate_xml | – month: 10 year: 2021 text: 2021-10-27 day: 27 |
PublicationDecade | 2020 |
PublicationPlace | San Francisco |
PublicationPlace_xml | – name: San Francisco – name: San Francisco, CA USA |
PublicationTitle | PloS one |
PublicationYear | 2021 |
Publisher | Public Library of Science Public Library of Science (PLoS) |
Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
References | MJ Ko (pone.0259153.ref025) 2019; 8 B Duchemann (pone.0259153.ref027) 2017; 50 CK Wu (pone.0259153.ref022) 2018; 71 N Veronese (pone.0259153.ref038) 2020; 7 Heart Protection Study Collaborative G (pone.0259153.ref036) 2011; 377 C Wu (pone.0259153.ref004) 2020; 180 SS Chang (pone.0259153.ref024) 2021; 75 CC Lai (pone.0259153.ref020) 2012; 106 B Ley (pone.0259153.ref018) 2017; 14 MS Ali (pone.0259153.ref034) 2016; 25 YJI Lee (pone.0259153.ref003) 2017; 8 Y Nan-Ping (pone.0259153.ref031) 2013; 13 M Kreuter (pone.0259153.ref005) 2019; 156 TY Xiong (pone.0259153.ref006) 2020; 41 SW Kim (pone.0259153.ref011) 2019; 10 PD Rosenblit (pone.0259153.ref021) 2019; 19 B. Southern (pone.0259153.ref040) 2020 AW Wong (pone.0259153.ref007) 2020; 158 N Azadeh (pone.0259153.ref017) 2017; 152 DS Fedson (pone.0259153.ref014) 2020; 11 MD Solomon (pone.0259153.ref010) 2020; 383 K Maneechotesuwan (pone.0259153.ref002) 2015; 148 CY Hsieh (pone.0259153.ref033) 2015; 114 C Mihai (pone.0259153.ref039) 2020; 79 L Todorova (pone.0259153.ref037) 2011; 105 A Tufan (pone.0259153.ref009) 2020; 50 N Jones (pone.0259153.ref019) 2012; 21 MY Wu (pone.0259153.ref028) 2018; 18 CL Cheng (pone.0259153.ref023) 2014; 24 YH Li (pone.0259153.ref016) 2013; 10 PL Molyneaux (pone.0259153.ref030) 2013; 22 SJ Gurczynski (pone.0259153.ref001) 2018; 314 G Sheng (pone.0259153.ref008) 2020; 157 M Kreuter (pone.0259153.ref015) 2017; 72 CY Hsieh (pone.0259153.ref032) 2019; 11 DS Hui (pone.0259153.ref029) 2005; 60 S Vedel-Krogh (pone.0259153.ref035) 2015; 10 WYT Tan (pone.0259153.ref012) 2020; 10 V Castiglione (pone.0259153.ref013) 2020; 6 AL Olson (pone.0259153.ref026) 2018; 27 |
References_xml | – volume: 180 start-page: 934 issue: 7 year: 2020 ident: pone.0259153.ref004 article-title: Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan publication-title: China. JAMA Intern Med doi: 10.1001/jamainternmed.2020.0994 – volume: 41 start-page: 1798 issue: 19 year: 2020 ident: pone.0259153.ref006 article-title: Coronaviruses and the cardiovascular system: acute and long-term implications publication-title: Eur Heart J doi: 10.1093/eurheartj/ehaa231 – volume: 158 start-page: 1069 issue: 3 year: 2020 ident: pone.0259153.ref007 article-title: Practical Considerations for the Diagnosis and Treatment of Fibrotic Interstitial Lung Disease During the COVID-19 Pandemic publication-title: Chest – volume: 13 start-page: 152 issue: 1 year: 2013 ident: pone.0259153.ref031 article-title: Comparisons of medical utilizations and categorical diagnoses of emergency visits between the elderly with catastrophic illness certificates and those without publication-title: BMC Health Serv Res doi: 10.1186/1472-6963-13-152 – volume: 156 start-page: 706 issue: 4 year: 2019 ident: pone.0259153.ref005 article-title: Association of Angiotensin Modulators With the Course of Idiopathic Pulmonary Fibrosis. publication-title: Chest doi: 10.1016/j.chest.2019.04.015 – volume: 6 start-page: 258 issue: 4 year: 2020 ident: pone.0259153.ref013 article-title: Statin therapy in COVID-19 infection publication-title: Eur Heart J Cardiovasc Pharmacother doi: 10.1093/ehjcvp/pvaa042 – volume: 152 start-page: 842 issue: 4 year: 2017 ident: pone.0259153.ref017 article-title: The Role of Infection in Interstitial Lung Diseases publication-title: A Review. CHEST doi: 10.1016/j.chest.2017.03.033 – volume: 21 start-page: 256 issue: S1 year: 2012 ident: pone.0259153.ref019 article-title: A systematic review of validated methods for identifying pulmonary fibrosis and interstitial lung disease using administrative and claims data publication-title: Pharmacoepidemiol Drug Saf doi: 10.1002/pds.2338 – volume: 79 start-page: 668 issue: 5 year: 2020 ident: pone.0259153.ref039 article-title: COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2020-217442 – volume: 50 start-page: 620 issue: Si-1 year: 2020 ident: pone.0259153.ref009 article-title: COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs publication-title: Turk J Med Sci doi: 10.3906/sag-2004-168 – volume: 377 start-page: 469 issue: 9764 year: 2011 ident: pone.0259153.ref036 article-title: C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20536 patients in the Heart Protection Study publication-title: The Lancet doi: 10.1016/S0140-6736(10)62174-5 – volume: 50 start-page: 1602419 issue: 2 year: 2017 ident: pone.0259153.ref027 article-title: Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris publication-title: Eur Respir J doi: 10.1183/13993003.02419-2016 – volume: 22 start-page: 376 issue: 129 year: 2013 ident: pone.0259153.ref030 article-title: The role of infection in the pathogenesis of idiopathic pulmonary fibrosis. publication-title: Eur Respir Rev doi: 10.1183/09059180.00000713 – volume: 25 start-page: 114 issue: Suppl 1 year: 2016 ident: pone.0259153.ref034 article-title: Methodological comparison of marginal structural model, time-varying Cox regression, and propensity score methods: the example of antidepressant use and the risk of hip fracture publication-title: Pharmacoepidemiol Drug Saf doi: 10.1002/pds.3864 – volume: 8 start-page: e2860 issue: 6 year: 2017 ident: pone.0259153.ref003 article-title: Simvastatin treatment boosts benefits of apoptotic cell infusion in murine lung fibrosis publication-title: Cell Death Dis doi: 10.1038/cddis.2017.260 – volume: 8 start-page: e011320 issue: 8 year: 2019 ident: pone.0259153.ref025 article-title: Time and Dose Dependent Association of Statin Use With Risk of Clinically Relevant NewOnset Diabetes Mellitus in Primary Prevention: A Nationwide Observational Cohort Study publication-title: J Am Heart Assoc doi: 10.1161/JAHA.118.011320 – volume: 148 start-page: 1164 issue: 5 year: 2015 ident: pone.0259153.ref002 article-title: Simvastatin Suppresses Airway IL-17 and Upregulates IL-10 in Patients With Stable COPD publication-title: Chest doi: 10.1378/chest.14-3138 – volume: 105 start-page: 1296 issue: 9 year: 2011 ident: pone.0259153.ref037 article-title: TGFβ2-induced matrix production by bronchial fibroblasts in asthma: Budesonide and formoterol effects publication-title: Respir Med doi: 10.1016/j.rmed.2011.03.020 – volume: 10 start-page: 151 issue: 2 year: 2013 ident: pone.0259153.ref016 article-title: Effects of rosuvastatin on expression of angiotensin-converting enzyme 2 after vascular balloon injury in rats publication-title: J Geriatr Cardiol – volume: 383 start-page: 691 issue: 7 year: 2020 ident: pone.0259153.ref010 article-title: The Covid-19 Pandemic and the Incidence of Acute Myocardial Infarction publication-title: N Engl J Med doi: 10.1056/NEJMc2015630 – volume: 24 start-page: 500 issue: 6 year: 2014 ident: pone.0259153.ref023 article-title: Validation of acute myocardial infarction cases in the national health insurance research database in taiwan publication-title: J Epidemiol doi: 10.2188/jea.JE20140076 – volume: 10 start-page: 17458 issue: 1 year: 2020 ident: pone.0259153.ref012 article-title: Statin use is associated with lower disease severity in COVID-19 infection publication-title: Sci Rep doi: 10.1038/s41598-020-74492-0 – year: 2020 ident: pone.0259153.ref040 article-title: Patients with interstitial lung disease and pulmonary sarcoidosis are at high risk for severe illness related to COVID-19. publication-title: Cleve Clin J Med – volume: 14 start-page: 880 issue: 6 year: 2017 ident: pone.0259153.ref018 article-title: Code-based Diagnostic Algorithms for Idiopathic Pulmonary Fibrosis. Case Validation and Improvement. publication-title: Ann Am Thorac Soc doi: 10.1513/AnnalsATS.201610-764OC – volume: 11 start-page: 349 year: 2019 ident: pone.0259153.ref032 article-title: Taiwan’s National Health Insurance Research Database: past and future publication-title: Clin Epidemiol doi: 10.2147/CLEP.S196293 – volume: 157 start-page: 1175 issue: 5 year: 2020 ident: pone.0259153.ref008 article-title: Viral Infection Increases the Risk of Idiopathic Pulmonary Fibrosis: A Meta-Analysis publication-title: Chest doi: 10.1016/j.chest.2019.10.032 – volume: 19 start-page: 61 issue: 8 year: 2019 ident: pone.0259153.ref021 article-title: Extreme Atherosclerotic Cardiovascular Disease (ASCVD) Risk Recognition. publication-title: Curr Diab Rep doi: 10.1007/s11892-019-1178-6 – volume: 114 start-page: 254 issue: 3 year: 2015 ident: pone.0259153.ref033 article-title: Validating the diagnosis of acute ischemic stroke in a National Health Insurance claims database publication-title: J Formos Med Assoc doi: 10.1016/j.jfma.2013.09.009 – volume: 18 start-page: 341 issue: 1 year: 2018 ident: pone.0259153.ref028 article-title: Acupuncture decreased the risk of coronary heart disease in patients with rheumatoid arthritis in Taiwan: a Nationwide propensity score-matched study publication-title: BMC Complement Altern Med doi: 10.1186/s12906-018-2384-5 – volume: 11 start-page: e00398 issue: 2 year: 2020 ident: pone.0259153.ref014 article-title: Hiding in Plain Sight: an Approach to Treating Patients with Severe COVID-19 Infection publication-title: mBio. doi: 10.1128/mBio.00398-20 – volume: 72 start-page: 148 issue: 2 year: 2017 ident: pone.0259153.ref015 article-title: Effect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosis publication-title: Thorax. doi: 10.1136/thoraxjnl-2016-208819 – volume: 71 start-page: 1273 issue: 11 year: 2018 ident: pone.0259153.ref022 article-title: The Taiwan Heart Registries: Its Influence on Cardiovascular Patient Care publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2018.02.006 – volume: 7 start-page: 170 year: 2020 ident: pone.0259153.ref038 article-title: Use of Corticosteroids in Coronavirus Disease 2019 Pneumonia: A Systematic Review of the Literature publication-title: Front Med (Lausanne) doi: 10.3389/fmed.2020.00170 – volume: 314 start-page: L6 issue: 1 year: 2018 ident: pone.0259153.ref001 article-title: IL-17 in the lung: the good, the bad, and the ugly publication-title: Am J Physiol Lung Cell Mol Physiol doi: 10.1152/ajplung.00344.2017 – volume: 10 start-page: e0140571 issue: 10 year: 2015 ident: pone.0259153.ref035 article-title: Statin Use Is Associated with Reduced Mortality in Patients with Interstitial Lung Disease publication-title: PloS one doi: 10.1371/journal.pone.0140571 – volume: 27 start-page: 180077 issue: 150 year: 2018 ident: pone.0259153.ref026 article-title: The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype publication-title: Eur Respir Rev doi: 10.1183/16000617.0077-2018 – volume: 75 start-page: e14066 issue: 5 year: 2021 ident: pone.0259153.ref024 article-title: Sex differences in long-term cardiovascular outcomes among patients with acute myocardial infarction: A population-based retrospective cohort study publication-title: Int J Clin Pract doi: 10.1111/ijcp.14066 – volume: 10 start-page: 103 year: 2019 ident: pone.0259153.ref011 article-title: Statins and Inflammation: New Therapeutic Opportunities in Psychiatry publication-title: Front Psychiatry doi: 10.3389/fpsyt.2019.00103 – volume: 106 start-page: 1566 issue: 11 year: 2012 ident: pone.0259153.ref020 article-title: Idiopathic pulmonary fibrosis in Taiwan–A population-based study publication-title: Respir Med doi: 10.1016/j.rmed.2012.07.012 – volume: 60 start-page: 401 issue: 5 year: 2005 ident: pone.0259153.ref029 article-title: Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors publication-title: Thorax doi: 10.1136/thx.2004.030205 |
SSID | ssj0053866 |
Score | 2.4001765 |
Snippet | Purpose To determine the effects of statins and steroids on the risk of coronary artery disease (CAD) and stroke in patients with interstitial lung disease and... To determine the effects of statins and steroids on the risk of coronary artery disease (CAD) and stroke in patients with interstitial lung disease and... PurposeTo determine the effects of statins and steroids on the risk of coronary artery disease (CAD) and stroke in patients with interstitial lung disease and... Purpose To determine the effects of statins and steroids on the risk of coronary artery disease (CAD) and stroke in patients with interstitial lung disease and... |
SourceID | plos doaj pubmedcentral proquest gale crossref |
SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database |
StartPage | e0259153 |
SubjectTerms | Angina pectoris Biology and Life Sciences Cardiovascular disease Care and treatment Chronology Codes Complications and side effects Confidence intervals Consent Coronary artery Coronary artery disease Coronary heart disease Coronary vessels Corticoids Corticosteroids Diabetes Fibrosis Health insurance Health risks Heart attacks Heart diseases Hospitals Hypertension Infections Ischemia Kidney diseases Lung diseases Medical research Medicine and Health Sciences Mortality Patient outcomes Physical Sciences Population studies Population-based studies Pulmonary fibrosis Rheumatism Sleep disorders Software Statins Statistical analysis Steroid hormones Steroids Steroids (Drugs) Stroke Stroke (Disease) Vein & artery diseases Viral infections |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3BbtQwELXQnrggWkANlGIQEnBIuxsnE5vbgqgKEiABRb1Fjh2XiCWJNruHfg8_ykzijWoJqRy4el6y2ZnxzDgZPzP2XICoMrAQC2fSmFJurBPpYkiMWmgptcxpN_LHT3B2nn64yC6uHfVFPWEjPfCouBNdYdIkihOn5mnppDKYkcEuMK0Z0GAo-mLO2y2mxhiMsxjAb5QT-eLE2-W4a5vqGLO8WmQiSEQDX_8UlWfdqu2DkjNsmLyWgU7vsju-dOTL8ZH32K2q2Wd7fnL2_KVnkH51j_0eOYl73jpOO4bqpue6sZxIEdra4njDDVEX6PUVH5o6r7j_UuNx6_ZnxeuGe9rVntP7Wk7cEmtqLkCn5SsME8FV3Xb1a7ylwzV429f9a77kl-NT8W46KYwPlLb32fnpu29vz2J_GkNsANQmBiilcc5KqOZK2rKUmbI45StMb6lVRoq5w_F8jrgFSVRWQZk7sLbEISkesFmD-j9gHBMnOChtacok1ZnTQmMZpwAXxfgTcxExsTNNYTxVOZ2YsSqG7285LllGlRdk0MIbNGLxdFU3UnXcgH9DVp-wRLQ9DKD7Fd79ipvcL2JPyGeKcdfqFC6KJUhqDMD6N2LPBgSRbTTUzXOpt31fvP_8_R9AX78EoBce5FpUh9F-BwX-JyLxCpCHARJDhgnEB-ThO630RZJJUCgFiVfuvP7v4qeTmG5KHXpN1W4HTJ5nuJjPI5YHsyVQcChp6h8Dozmx6qUCHv4PizxitxPqO8L6IskP2Wyz3laPsXDclEdDjPgDXZZv7Q priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lj9MwELagXLggloe2yy4YhAQcstvmMba5oIJYLUiABCzqLXLsuFSUJDTtYX_P_lFmEjdgCQFX-3MeHs_D9vgzY48TSMoMLESJM2lELjfSsXQRxEZNtZRaCjqN_O49nJ2nb-fZ3C-4tT6tcmcTO0Nta0Nr5CdxJkFJtLfyRfMjolujaHfVX6FxlV0j6jJK6RLzYcKFugzgj8slYnripXPc1FV5jL5eTbMkcEcda_9gm0fNqm6DwDNMm_zND53eZDd8AMlnvcT32JWyusX2vIq2_KnnkX52m132zMQtrx2nc0PLquW6spyoEeqlxfKKGyIw0OsL3qV2XnC_X-Nx6_pbyZcV9-SrLadVW04ME2tKMcChy1doLIJWzXb1vX-kw5l43S7b53zGF_1X8Wa4L4x3xLZ32Pnp68-vziJ_J0NkANQmAiikcc5KKCdK2qKQmbKo-CU6udQqI5OJw3IxQdyUalRWQiEcWFtgkUzuslGF_b_POLpPcFDYwhRxqjOnE43BnAKcGuMrJsmYJTvR5MYTltO9Gau824UTOHHpuzwngeZeoGMWDa2anrDjH_iXJPUBS3TbXUG9XuRee3NdYuRGPDtOTdLCSWUwLAQ7xdjKgAYzZg9ozOT92dXBaOQzkJQegFHwmD3qEES5UVFOz0Jv2zZ_8-HLf4A-fQxATzzI1dgdRvtzFPhPROUVIA8DJBoOE1Tv0wjf9Uqb_1IxbLkb9X-ufjhU00MpT68q622HESLDKb0YMxFoS9DBYU21_NrxmhO3XprAwd9ffo9djymvCOOHWByy0Wa9LY8wMNwU9zvt_wn5TGhE priority: 102 providerName: ProQuest |
Title | Effects of statins and steroids on coronary artery disease and stroke in patients with interstitial lung disease and pulmonary fibrosis: A general population study |
URI | https://www.proquest.com/docview/2586980368 https://www.proquest.com/docview/2587752497 https://pubmed.ncbi.nlm.nih.gov/PMC8550436 https://doaj.org/article/ae0648014f904bf89c2516d1223c6a6c http://dx.doi.org/10.1371/journal.pone.0259153 |
Volume | 16 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwELe27oUXxPjQOkYxCAl4SJVP20FCqJtaBtIGGhT1LXKcuFSUpCStRF_4Z_hHuXPciEhDwEsefGc3Pfs-HJ9_R8iTgAV5xDLmBFqFDrpcR_pCO8xXsSeFkILjbeSLS3Y-Dd_Ootke2dVstQKsr93aYT2pabUcfv-2fQUK_9JUbeDertNwVRb5EHx4DFq8Tw7AN3FU1YuwPVcA7Tanlxi1wOu4gb1M96dROs7KYPq3lru3WpZ1JyztJlX-5qUmt8hNG17SUbMeDsleXtwmh1aBa_rMokw_v0N-NrjFNS01xVtFi6KmssgoAieUiwzaC6oQ3kBWW2oSP7fUnuZYvqr8ktNFQS00a03xmy5F_IkKExBgYdMlmJJOr9Vm-bUZUsM-vawX9Qs6ovPmreiqrSZGDeztXTKdjD-enTu2YoOjGIvXDmOpUFpnguVuLLI0FVGcgVnIwQWGWaxE4Gpo5y7weUiJo5ylXLMsS6FJBPdIrwD5HxEKzpVplmapSv1QRloGEkK9mMHGGX7CDfok2E1NoiycOVbVWCbmjI7DtqYReYITmtgJ7ROn7bVq4Dz-wn-Ks97yIhi3aSireWJ1O5E5xHWIwqNjN0y1iBUEjSzzIPJSTDLVJw9xzSTNzdbWpCQjJjB5AGLkPnlsOBCQo8CMn7nc1HXy5t2nf2D6cNVhemqZdAniUNLesoD_hEBfHc6TDieYFdUhH-EK30mlTvxIsBioTEDP3aq_nvyoJeOgmMVX5OXG8HAewYaf9wnvaEtHwF1KsfhsUM8ReS8M2PF_zuB9csPHNCQIN3x-QnrrapM_gDhynQ7IPp9xeIozD5-T1wNycDq-fH81MF9mBsZ04PPH-BfOhHxq |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lj9MwELaWcoALYnloyy6sQSDgkN00D8dGQqg8Vi37QIJd1Ftw7LhbUZLQtEL9Pdz5jcwkTiASAi57tcdJ6xl_Hscz3xDy0Gd-GjLNHN-owMEt15EeNw7zlBhIziWPMBv5-ISNzoK3k3CyQX40uTAYVtlgYgXUOlf4jXzfCzkTHPCWvyi-Olg1Cm9XmxIatVkcputvcGQrn49fg34fed7Bm9NXI8dWFXAUY2LpMJZwZYzmLHUF10nCQ6HBdFOA6UALxX3XQHvkgtwAe0SYsiQyTOsEmrgPz71ELsPG6-KKiibtAQ-wgzGbnudHg31rDXtFnqV74FuIQeh3tr-qSkC7F_SKeV52HN1umOZv-97BdXLNOqx0WFvYJtlIsxtk00JCSZ9Y3uqnN8n3mgm5pLmhmKc0y0oqM02RiiGfaWjPqELCBLlY0yqUdE3t_ZCVW-SfUzrLqCV7LSl-JabIaLHAkAZYKnQO4NQZVazmX-pHGjj55-WsfEaHdFr_Klq09cloRaR7i5xdiLZuk14G879FKGzXzLBEJyrxAhka6UtwHgWDozi8wvX7xG9UEytLkI51OuZxdesXwUGpnvIYFRpbhfaJ044qaoKQf8i_RK23skjvXTXki2ls0SKWKXiKyOtjhBskhgsFbijTA_DlFJNM9cku2kxc58q2IBUPGcdwBPC6--RBJYEUHxnGEE3lqizj8buP_yH04X1H6LEVMjlMh5I2bwP-E1KHdSR3OpIAVKrTvYUW3sxKGf9a0jCysfo_d99vu_GhGBeYpfmqkomi0AtE1CdRZ7V0Jrjbk83OKx515PILfHbn7y_fJVdGp8dH8dH45HCbXPUwpgl8Fy_aIb3lYpXeBad0mdyrkICSTxcNPT8BSXilXQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELdGkRAviPFHKwxmEAh4yNrEiWMjIVQY1cpgINhQ34LjxKWiJKFphfp5-BZ8Ou4SJxAJAS97tc9O4jv_fI7vfibkHuMsDXjCHWa07-CS6yhPGId7WrpKCCVCzEZ-fcwPT_2X02C6RX40uTAYVtlgYgXUSa7xH_nACwSXAvBWDIwNi3h7MH5afHXwBik8aW2u06hN5CjdfIPtW_lkcgC6vu954xcnzw8de8OAozmXK4fzWGhjEsHToRRJHItAJmDGKUC2n0gt2NBAeTgEORdrZJDyODQ8SWIoEgz6PUfOhyxwcY6F03azBzjCuU3VY6E7sJaxX-RZug9-hnQD1lkKqxsD2nWhVyzysuP0dkM2f1sDx5fJJeu80lFtbdtkK82ukG0LDyV9aDmsH10l32tW5JLmhmLO0jwrqcoSirQM-TyB8oxqJE9Qyw2twko31J4VWbll_jml84xa4teS4h9jiuwWSwxvgGlDFwBUnVbFevGl7tLMY_jmefmYjuisfitatHeV0YpU9xo5PRNtXSe9DMZ_h1BYurnhcRLr2PNVYBRT4EhKDttyeMSQ9QlrVBNpS5aOd3YsouoEMIRNUz3kESo0sgrtE6dtVdRkIf-Qf4Zab2WR6rsqyJezyCJHpFLwGpHjx8ihHxshNbikPHHBr9Nccd0ne2gzUZ032wJWNOICQxPAA--Tu5UE0n1kOHFmal2W0eTNh_8Qev-uI_TACpkchkMrm8MB34Q0Yh3J3Y4kgJbuVO-ghTejUka_pje0bKz-z9V32mrsFGMEszRfVzJhGHi-DPsk7MyWzgB3a7L5p4pTHXn9fMZv_P3he-QCgE70anJ8dJNc9DC8CdwYL9wlvdVynd4C_3QV366AgJKPZ408PwHKy6mT |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+statins+and+steroids+on+coronary+artery+disease+and+stroke+in+patients+with+interstitial+lung+disease+and+pulmonary+fibrosis%3A+A+general+population+study&rft.jtitle=PloS+one&rft.au=Yeh%2C+Jun-Jun&rft.au=Lin%2C+Cheng-Li&rft.au=Hsu%2C+Nai-Hua&rft.au=Kao%2C+Chia-Hung&rft.date=2021-10-27&rft.issn=1932-6203&rft.eissn=1932-6203&rft.volume=16&rft.issue=10&rft.spage=e0259153&rft_id=info:doi/10.1371%2Fjournal.pone.0259153&rft.externalDBID=n%2Fa&rft.externalDocID=10_1371_journal_pone_0259153 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon |